DOI:
10.1055/s-00034923
Adipositas - Ursachen, Folgeerkrankungen, Therapie
LinksClose Window
References
Portron A, Jadidi S, Sarkar N, DiMarchi R, Schmitt C.
Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 after single subcutaneous administration in healthy subjects.
Diabetes Obes Metab 2017;
19 (10) 1446-1453.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.